We are monitoring the impact of COVID-19 on MEA Advanced Infusion Systems Market Get in touch with us for detailed analysis Know More
Share on

Middle East and Africa Advanced Infusion Systems Market Research Report – Segmented By Application, Product, End-User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1229
Pages: 145

The size of the Middle East and Africa Advanced Infusion Systems Market is estimated to grow at a slow rate during the forecast period.

The growth of the MEA advanced infusion systems market can be attributed to the increasing prevalence of chronic diseases, increased rate of population, and growing demand for minimally invasive procedures. Chronic diseases such as diabetes, hypertension, and cancer are increasing rapidly in developing, low- and middle-income regions around the MEA. The number of people with diabetes increased from 108 million in the early 1980s to 425 million in 2015. The global prevalence of diabetes among adults over 18 years of age rose to 8.58% in 2015, from 4.78% in 1980.

Other factors such as the increasing number of hospitals and clinics, more expenditure on healthcare are boosting the growth of the MEA advanced infusion systems market. Total health expenditure is growing faster than gross domestic product; in low-and-middle-income countries, the average is about 6.5%, while the average is at 4.4% in high-income countries. An advanced infusion system can offer efficient delivery of drugs, amino acids, minerals, and several essential micronutrients, creating opportunities in the MEA market. Companies aim to launch smart infusion systems with greater therapeutic efficacy and eliminate user risks, automation, drug libraries, operators, and safety features for precise and precise patient results to help manage controlled fluids in patient systems.

However, strict regulations regarding product approval and the high cost associated with advanced infusion systems may hamper the growth of this market. Moreover, concerns about the consequences of improper use and low-income countries that cannot afford to provide such systems to their medical units are the major causes that create obstacles for the growth of the MEA advanced infusion systems market. In addition, inappropriate disposal of infusion pumps leads to growing concerns for patient and environmental safety.

This research report on the MEA Advanced Infusion Systems Market is segmented & sub-segmented into the following categories:

By Application Type:

  • Clinical Nutrition
  • Chemotherapy
  • Pain Management
  • Diabetes
  • Asthma Treatment

By Product Type:

  • Disposable Infusion System
  • Elastomeric Infusion System
  • Ambulatory Infusion System
  • Volumetric Infusion System
  • Patient Controlled Analgesia Pump
  • Syringe Infusion System
  • Implantable Infusion System

By End-Users:

  • Diagnostic Centers
  • Hospitals
  • Ambulatory Surgical Centers

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The Kingdom of Saudi Arabia regional market holds the largest share of the MEA advanced infusion systems market due to the presence of prominent players, a large patient base, and the high adoption of infusion systems in chronic disease management in this region. The World Health Organization (WHO) has reported that Saudi Arabia ranks second in the Middle East region and seventh across the globe for having a high prevalence of diabetes. It is estimated that around 7.23 million people have diabetes, and nearly 3.21 million have prediabetes.

The regional market in Egypt is analyzed to hold the second-largest market share of the MEA advanced infusion systems market owing to the increase in healthcare spending, favorable reimbursement policies, and well-established healthcare infrastructure in this region. Diabetes is a rapidly growing health problem in Egypt with a significant impact on healthcare society affecting human resources. Based on recent data, in Egypt, the prevalence of type 2 diabetes is reported to be approximately 15.89% of all adults aged 20-79 years.

The regional market in South Africa is predicted to grow at a CAGR of 3% during the forecast period. This market growth can be attributed to the high adoption rate of these devices in hospitals, coupled with a growing awareness of their benefits, supportive local and international healthcare authorities to provide a better quality of medical facilities, and availability of funds to encourage research and development activities.

KEY MARKET PLAYERS:

Hospira, Inc. is a market leader in infusion technologies globally. The major players in these markets are AngioDynamics, Inc., Medtronic, Inc., Terumo Corporation, Johnson & Johnson, CareFusion Corporation, Animas Corporation, Baxter International, Inc., B. Braun Melsungen AG, I-Flow Corporation, and F. Hoffmann-La Roche Ltd.

1.Introduction                        

            1.1 Market Definition            

            1.2 Study Deliverables                       

            1.3 Base Currency, Base Year and Forecast Periods              

            1.4 General Study Assumptions                     

2. Research Methodology                              

            2.1 Introduction                     

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research         

                        2.2.3 Econometric Modelling

                        2.2.4 Expert Validation          

            2.3 Analysis Design                

            2.4 Study Timeline                 

3. Overview                            

            3.1 Executive Summary                     

            3.2 Key Inferences                 

            3.3 Epidemology                    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

            4.1 Market Drivers                 

            4.2 Market Restraints            

            4.3 Key Challenges                 

            4.4 Current Opportunities in the Market                  

5. Market Segmentation                                

            5.1 Application                       

                        5.1.1 Introduction      

                        5.1.2 Clinical Nutrition           

                        5.1.3 Chemotherapy  

                        5.1.4 Pain Management        

                        5.1.5 Diabetes

                        5.1.6 Asthma  

                        5.1.7  Y-o-Y Growth Analysis, By Application

                        5.1.8  Market Attractiveness Analysis, By Application          

                        5.1.9  Market Share Analysis, By Application

            5.2 Product                 

                        5.2.1 Introduction      

                        5.2.2 Disposable Infusion System      

                        5.2.3 Elastomeric Infusion System     

                        5.2.4 Ambulatory Infusion System    

                        5.2.5 Volumetric Infusion System      

                        5.2.6 Patient Controlled Analgesia Pump      

                        5.2.7 Syringe Infusion System

                        5.2.8 Implantable Infusion System    

                        5.2.9  Y-o-Y Growth Analysis, By Product      

                        5.2.10  Market Attractiveness Analysis, By Product  

                        5.2.11  Market Share Analysis, By Product    

            5.3 End-User              

                        5.3.1 Introduction      

                        5.3.2 Diagnostic Centers        

                        5.3.3 Hospitals

                        5.3.4 Ambulatory Surgical Centers    

                        5.3.5  Y-o-Y Growth Analysis, By End-User    

                        5.3.6  Market Attractiveness Analysis, By End-User  

                        5.3.7  Market Share Analysis, By End-User    

6. Geographical Analysis                                

            6.1 Introduction                     

                        6.1.1 Regional Trends

                        6.1.2 Impact Analysis 

                        6.1.3 Y-o-Y Growth Analysis  

                                    6.1.3.1 By Geographical Area

                                    6.1.3.2 By Application

                                    6.1.3.3 By Product

                                    6.1.3.4 By End-User

                        6.1.4  Market Attractiveness Analysis

                                    6.1.3.1 By Geographical Area

                                    6.1.3.2 By Application

                                    6.1.3.3 By Product

                                    6.1.3.4 By End-User

                        6.1.5  Market Share Analysis 

                                    6.1.3.1 By Geographical Area

                                    6.1.3.2 By Application

                                    6.1.3.3 By Product

                                    6.1.3.4 By End-User

            6.2 Middle-East                      

            6.3 Africa                   

7.Strategic Analysis                            

            7.1 PESTLE analysis                

                        7.1.1 Political 

                        7.1.2 Economic          

                        7.1.3 Social     

                        7.1.4 Technological    

                        7.1.5 Legal     

                        7.1.6 Environmental  

            7.2 Porter’s Five analysis                   

                        7.2.1 Bargaining Power of Suppliers  

                        7.2.2 Bargaining Power of Consumers          

                        7.2.3 Threat of New Entrants

                        7.2.4 Threat of Substitute Products and Services     

                        7.2.5 Competitive Rivalry within the Industry           

8.Market Leaders' Analysis                            

            8.1 Hospira, Inc.                     

                        8.1.1 Overview           

                        8.1.2 Product Analysis

                        8.1.3 Financial analysis          

                        8.1.4 Recent Developments   

                        8.1.5 SWOT analysis  

                        8.1.6 Analyst View     

            8.2 AngioDynamics, Inc.                    

            8.3 Medtronic, Inc.                

            8.4 Terumo Corporation                    

            8.5 Johnson & Johnson                      

            8.6 CareFusion Corporation               

            8.7 Animas Corporation                     

            8.8 Baxter International Inc.              

            8.9 B. Braun Melsungen AG               

            8.10 I-Flow Corporation                     

            8.11 F. Hoffmann-La Roche Ltd                     

9.Competitive Landscape                              

            9.1 Market share analysis                  

            9.2 Merger and Acquisition Analysis             

            9.3 Agreements, collaborations and Joint Ventures             

            9.4 New Product Launches                

10.Market Outlook and Investment Opportunities                           

Appendix                                

            a) List of Tables                      

            b) List of Figures                     

  1. Middle East & Africa Advanced Infusion Systems Market, By Application, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Clinical Nutrition Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Chemotherapy Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Pain Management Market, By Region, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Diabetes Market, By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Asthma Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Advanced Infusion Systems Market, By Product, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Disposable Infusion System Market, By Region, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Elastomeric Infusion System Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Ambulatory Infusion System Market, By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Volumetric Infusion System Market, By Region, From 2022 - 2027 (USD Million)
  12. Middle East & Africa Patient Controlled Analgesia Pump Market, By Region, From 2022 - 2027 (USD Million)
  13. Middle East & Africa Syringe Infusion System Market, By Region, From 2022 - 2027 (USD Million)
  14. Middle East & Africa Implantable Infusion System Market, By Region, From 2022 - 2027 (USD Million)
  15. Middle East & Africa Advanced Infusion Systems Market, By End users, From 2022 - 2027 (USD Million)
  16. Middle East & Africa Diagnostic Centers Market, By Region, From 2022 - 2027 (USD Million)
  17. Middle East & Africa Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  18. Middle East & Africa Ambulatory Surgical Centers Market, By Region, From 2022 - 2027 (USD Million)
  19. Middle East Advanced Infusion Systems Market, By Application, From 2022 - 2027 (USD Million)
  20. Middle East Advanced Infusion Systems Market, By Product, From 2022 - 2027 (USD Million)
  21. Middle East Advanced Infusion Systems Market, By End users, From 2020 to 2025 (USD Million
  22. Africa Advanced Infusion Systems Market, By Application, From 2022 - 2027 (USD Million)
  23. Africa Advanced Infusion Systems Market, By Product, From 2022 - 2027 (USD Million)
  24. Africa Advanced Infusion Systems Market, By End users, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample